Regentis Biomaterials Ltd. (RGNT) Operating cash flow 2023–2025
Regentis Biomaterials Ltd. (RGNT) annual operating cash flow history from SEC filings — net cash provided by operating activities each fiscal year.
-$1.4MFY2025 · since FY2023: -$1.2M → -$1.4M
| Fiscal year | Value | YoY |
|---|---|---|
| FY2025 | -$1.4M | -114.5% |
| FY2024 | -$641,000 | +47.5% |
| FY2023 | -$1.2M | — |
Source: SEC XBRL filings · For reference only · Not investment advice
More RGNT financial trends
RGNT RevenueRGNT Net incomeRGNT Net marginRGNT Gross profitRGNT Gross marginRGNT Operating incomeRGNT Operating marginRGNT Free cash flowRGNT Capital expendituresRGNT Return on equityRGNT Stock buybacksRGNT Dividends paidRGNT Total assetsRGNT Total liabilitiesRGNT Shareholders’ equityRGNT overview →